Skip to main content
Log in

Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland

A Cross-Sectional Study

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background and objective: Multiple drug use is common among old, frail nursing home residents who are, as a consequence, susceptible to adverse effects and drug interactions. This study uses the updated Beers criteria for potentially inappropriate drug (PID) use in older adults to determine the extent and nature of PIDs in older nursing home residents in Helsinki, Finland. The study also uses the Swedish, Finnish, INteraction X-referencing (SFINX) interaction database to assess the possibility of clinically significant class D (“clinically significant interaction, and the combination should be avoided”) drug-drug interactions (DDIs) in the same population.

Methods: This study is a cross-sectional assessment of all nursing home residents aged ≥65 years in Helsinki. The residents’ demographic information and medical data were collected from medical charts in February 2003.

Results: Of all nursing home residents in Helsinki, 82% (n = 1987) were eligible for analysis. Their mean age was 83.7 (SD 7.7) years, 80.7% were female and 69.5% were diagnosed with dementia. The mean number of drugs given on a regular basis per resident was 7.9 (SD 3.6) per day. Of the study population, 34.9% regularly used at least one PID. Residents taking PIDs were more likely to be taking psychotropic medication and to be taking nine or more drugs daily, and less likely to have a diagnosis of dementia, than patients not taking PIDs. The three most prevalent PIDs were: (i) short-acting benzodiazepines in greater than recommended doses (13.9% of all residents), of which temazepam >15 mg/day was the most commonly used agent and, indeed, the most common PID (taken by 13.5% of all residents); (ii) hydroxyzine (7.1%); and (iii) nitrofurantoin (6.3%). Together, these three PIDs accounted for 76.9% of all PID use. Of all residents, 4.8% were susceptible to a clinically significant DDI. The most common potential DDIs were related to the use of potassium-sparing diuretics, carbamazepine and codeine. Compared with residents not exposed to potential DDIs, residents exposed to potential DDIs were more likely to be younger, to have a prior history of stroke, to be taking psychotropics, to be taking nine or more drugs daily and to be taking PIDs.

Conclusion: Use of PIDs is very common among nursing home residents, and this increases the likelihood of DDIs. Monitoring patients for PID use and potential drug interactions could increase the quality of prescribing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III
Table IV
Fig. 1

Similar content being viewed by others

References

  1. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med 1991 Sep; 151(9): 1825–32

    Article  PubMed  CAS  Google Scholar 

  2. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997 Jul 28; 157(14): 1531–6

    Article  PubMed  CAS  Google Scholar 

  3. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts [published erratum appears in Arch Intern Med 2004 Feb 9; 164 (3): 298]. Arch Intern Med 2003 Dec 8–22; 163(22): 2716–24

    Article  PubMed  Google Scholar 

  4. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997 Feb 1; 156(3): 385–91

    PubMed  CAS  Google Scholar 

  5. Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7(2): 103–7

    PubMed  CAS  Google Scholar 

  6. Lääkeaineinteraktiot SFINX [online]. Available from URL: http://www.terveysportti.fi/ [Accessed 2008 Jul 11]

  7. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007 Jul 14; 370(9582): 173–84

    Article  PubMed  Google Scholar 

  8. Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992 Oct 15; 117(8): 684–9

    PubMed  CAS  Google Scholar 

  9. Williams B, Betley C Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995 May; 43(5): 513–9

    PubMed  CAS  Google Scholar 

  10. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 1997 Mar; 87(3): 404–9

    Article  PubMed  CAS  Google Scholar 

  11. Dhall J, Larrat EP, Lapane KL. Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002 Jan; 22(1): 88–96

    Article  PubMed  Google Scholar 

  12. Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc 2004 Jun; 52(6): 861–6

    Article  PubMed  Google Scholar 

  13. Gray SL, Hedrick SC, Rhinard EE, et al. Potentially inappropriate medication use in community residential care facilities. Ann Pharmacother 2003 Jul–Aug; 37(7–8): 988–93

    Article  PubMed  Google Scholar 

  14. Lau DT, Kasper JD, Potter DE, et al. Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res 2004 Oct; 39(5): 1257–76

    Article  PubMed  Google Scholar 

  15. Raivio MM, Laurila JV, Strandberg TE, et al. Use of inappropriate medications and their prognostic significance among inhospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006; 23(4): 333–43

    Article  PubMed  Google Scholar 

  16. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland [published erratum appears in Drugs Aging 2005; 22 (11): 965]. Drugs Aging 2005; 22(9): 793–800

    Article  PubMed  Google Scholar 

  17. Hosia-Randell H, Suominen M, Muurinen S, et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging 2007; 24(2): 147–54

    Article  PubMed  Google Scholar 

  18. Alanen HM, Finne-Soveri H, Noro A, et al. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland. Age Ageing 2006 Sep; 35(5): 508–13

    Article  PubMed  Google Scholar 

  19. Alanen HM, Finne-Soveri H, Noro A, et al. Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. Int J Geriatr Psychiatry 2006 Mar; 21(3): 288–95

    Article  PubMed  Google Scholar 

  20. Raivio MM, Laurila JV, Strandberg TE, et al. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 2007 May; 15(5): 416–24

    Article  PubMed  Google Scholar 

  21. Morris JN, Hawes C, Fries BE, et al. Designing the national Resident Assessment Instrument for nursing homes. Gerontologist 1990 Jun; 30(3): 293–307

    Article  PubMed  CAS  Google Scholar 

  22. Noro A, Finne-Soveri H, Björkgren M, et al. Quality and productivity in institutional care for elderly residents: benchmarking with the RAI. Helsinki: National Research and Development Centre for Welfare and Health (STAKES), 2005

    Google Scholar 

  23. Sjöqvist F. A new classification system of drug interactions [abstract no. 377]. Eur J Clin Pharmacol 1997; 52 Suppl.: A126

    Google Scholar 

  24. Suominen M, Muurinen S, Routasalo P, et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 2005 Apr; 59(4): 578–83

    Article  PubMed  CAS  Google Scholar 

  25. Burrows AB, Morris JN, Simon SE, et al. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 2000 Mar; 29(2): 165–72

    Article  PubMed  CAS  Google Scholar 

  26. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001 Feb; 49(2): 200–9

    Article  PubMed  CAS  Google Scholar 

  27. Gardner MJ, Altman DG, editors. Statistics with confidence: confidence intervals and statistical guidelines. 1st ed. London: BMJ Books, 1989

    Google Scholar 

  28. Pharmaca Fennica. Helsinki: Lääketietokeskus, 2007

  29. Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated [letter]? Arch Intern Med 2004 Aug 9–23; 164(15): 1701

    Article  PubMed  Google Scholar 

  30. Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatr 2006; 6: 1

    Article  PubMed  Google Scholar 

  31. Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents. The Bergen district nursing home (BEDNURS) study. Eur J Clin Pharmacol 2003 Sep; 59(5–6): 463–9

    Article  PubMed  Google Scholar 

  32. Perri 3rd M, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005 Mar; 39(3): 405–11

    Article  PubMed  Google Scholar 

  33. Lau DT, Kasper JD, Potter DE, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005 Jan 10; 165(1): 68–74

    Article  PubMed  Google Scholar 

  34. Wagner AK, Ross-Degnan D, Gurwitz JH, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med 2007 Jan 16; 146(2): 96–103

    PubMed  Google Scholar 

  35. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007 Jul 14; 370(9582): 185–91

    Article  PubMed  CAS  Google Scholar 

  36. Astrand B, Astrand E, Antonov K, et al. Detection of potential drug interactions: a model for a national pharmacy register. Eur J Clin Pharmacol 2006 Sep; 62(9): 749–56

    Article  PubMed  Google Scholar 

  37. Pharmaceutical specialities in Sweden [in Swedish; online]. Available from URL: http://www.fass.se/ [Accessed 2008 Jul 11]

  38. Bjorkman IK, Fastbom J, Schmidt IK, et al. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group: drug-drug interactions in the elderly. Ann Pharmacother 2002 Nov; 36(11): 1675–81

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study.

The authors give their warmest thanks to the City of Helsinki.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hosia-Randell, H.M.V., Muurinen, S.M. & Pitkälä, K.H. Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland. Drugs Aging 25, 683–692 (2008). https://doi.org/10.2165/00002512-200825080-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200825080-00005

Keywords

Navigation